Ardena Launches Life Science Ingredients Arm

Belgian contract development and manufacturing organization (CDMO) Ardena has...
Belgian contract development and manufacturing organization (CDMO) Ardena has launched Ardena LSI, a new business arm dedicated to the sale of chemical ingredients and intermediates for the life science industry. © Ardena

Belgian contract development and manufacturing organization (CDMO) Ardena has launched Ardena LSI, a new business arm dedicated to the sale of chemical ingredients and intermediates for the life science industry.

Ardena will manufacture ingredients including 1,4-butanediol diglycidyl ether (BDDE) and 1-ethyl-3-3(3-dimethylaminopropyl) carbodiimide hydrochloride (EDC-HCl) Ultra-pure at its GMP-certified plants in Europe. The ingredients can be used by pharmaceutical manufacturers in the development of drug products and for applications in health care and cosmetics products such as dermal fillers.

“We have built up extensive experience as a CDMO in the area of chemical synthesis and through Ardena LSI we are now harnessing that experience to manufacture high-quality chemical ingredients that are essential for pharmaceutical manufacturers in European markets,” said CEO Harry Christiaens.

Ardena was formed in 2017 from the merger of three previously acquired companies – Pharmavize in Belgium, Crystallics and Analytical Biochemical Laboratory in the Netherlands.

The Ghent-headquartered company has continued its acquisition strategy since then, having acquired two companies in 2018, notably ChemConnection in March and Syntagon in May. Originating from Organon, part of Merck Sharp & Dohme, in 2012, Netherlands-based ChemConnection is a contract manufacturer of novel APIs and nanomedicines.

Syntagon, another CDMO specializing in APIs and excipients as well as GMP chromatographic purification processes, was Ardena’s first acquisition outside the Benelux region, bringing sites in Sweden and Latvia. Ardena now operates six facilities, including its headquarters in Ghent, and sites in Oss, Amsterdam and Assen in the Netherlands.

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

most read

Photo
21.03.2025 • News

What’s Next for Pharma Supply Chains?

Sudden shifts in demand, supply shortages and global collapse have put immense pressure on pharmaceutical logistics. To address these challenges, PHARMAP 2025 brings together industry experts to discover AI-driven supply chain optimisation, strategic logistics partnerships and digital solutions that enhance efficiency and resilience in the pharmaceutical supply chain.